European investment trends by UK investment trusts, Kepler Analysis

Europe

In this research note, Kepler explores the performance and investment landscape of European equities, emphasizing the importance of focusing on individual companies rather than macroeconomic conditions. The report highlights several leading companies, such as Novo Nordisk and ASML, and discusses how European equity markets, including those covered by Fidelity European Trust plc (LON:FEV) and JPMorgan European Discovery plc (LON:JEDT), benefit from global revenues and trends. The note also examines fund flows and geographical weightings, suggesting that despite a challenging macroeconomic outlook, European equities offer compelling opportunities driven by world-class companies in various sectors.

What this piece isn’t trying to do is cast any economic forecasts for European countries, and in truth, it’s not hard to find plenty of negatives to talk about if one wants to. At the heart of things, we are just intrigued by the fact that last year European stock markets performed well, driven by good operational performance by many of its largest companies, rather than by a valuation recovery from the lows reached in 2022, but at the same time investors continued to shun the region. And as it turns out the Europe that fund managers invest into has a brighter economic track record than the Europe we think of when we just look at the sizes of the economies that make up the whole. We’ve been asked a fair bit this year whether very strong fund flows into US equities are a signal that it’s time to jump ship, and our view is that when one is dealing with explosively growing companies, it can become complicated to answer such a question. What seems less complicated to us is that Europe has shown it has some great, world-leading companies in which investors have shown limited interest by comparison to the Magnificent Seven, and yet the economic reality for many countries is much more positive than the common narrative. This seems to us to be a convergence of things that could lead to very strong performance once investors fully grasp the situation.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

Investors are returning to Europe’s broadest index

The STOXX 600 has passed 600 for the first time as investors rotate into stable earnings and real assets across Europe.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

JPMorgan European Discovery Trust November Factsheet 2025

As at 30 November 2025, the Trust reported net assets of £651.5 million, positive longer term performance against its benchmark, and a diversified portfolio positioned to benefit from recovery and growth across European smaller companies.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

Search

Search